2005-2018年期间在韩国甲状腺癌特异性死亡率,过度诊断问题的后果:全国基于人口的队列研究
Kyeong Jin Kim1, Jimi Choi1, Sue K Park2,3
1Department of Internal Medicine, Division of Endocrinology and Metabolism, Korea University College of Medicine Seoul.
International journal of surgery (London, England)
|June 14, 2024
概括
甲状腺癌发病率下降,但2015年以来诊断的患者的死亡率增加. 这凸显了针对甲状腺癌 (TC) 诊断和治疗策略的需求,以管理进展风险并减少过度治疗.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 由于对过度诊断和过度治疗的担忧,甲状腺癌 (TC) 的诊断和治疗已经发展.
- 关于这些变化对TC特异性死亡率的影响的研究有限.
研究的目的:
- 评估甲状腺癌特定死亡率的趋势.
- 评估诊断和治疗改变对TC死亡率的影响.
主要方法:
- 一项基于人口的队列研究利用了来自韩国国家健康保险服务-国家健康信息数据库的434,228名TC患者的数据.
- 计算年龄和性别标准化每1000人年死亡率,以分析基于诊断年份的TC特定死亡率趋势.
主要成果:
- 从2012年到2015年,TC发病率显著下降.
- 甲状腺特异性死亡率最初下降,但从2013年到2018年增加,特别是在接受全甲状腺切除术或没有甲状腺切除术的患者中.
- 在接受甲状腺切除术或甲状腺切除术的患者中,死亡率保持稳定.
结论:
- 自2015年以来,被诊断为甲状腺癌的患者的特定死亡率有所上升,与发病率下降形成鲜明对比.
- 强调需要对高风险的TC患者进行适当的诊断和治疗.
- 强调在低风险的TC病例中减少过度诊断和过度治疗的重要性.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


